問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

莊正皓
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

2Cases

2022-11-01 - 2025-01-07

Phase III

Completed
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 Over at Least 52 Weeks in Patients With Idiopathic Pulmonary Fibrosis (IPF)
  • Condition/Disease

    Idiopathic Pulmonary Fibrosis

  • Test Drug

    BI 1015550

Participate Sites
8Sites

Not yet recruiting8Sites

2022-11-01 - 2025-04-14

Phase III

Completed
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 Over at Least 52 Weeks in Patients With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
  • Condition/Disease

    Lung Diseases, Interstitial

  • Test Drug

    BI 1015550

Participate Sites
9Sites

Not yet recruiting8Sites

Recruiting1Sites